This compound is a chemical compound used as a pharmaceutical intermediate in the manufacturing of the drug deucravacitinib.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2245111-16-2
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-, methyl ester
pharmaceutical intermediate
6-chloro-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
n.a
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
Zinc(II) 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate
Zinc salt pharmaceutical intermediate
Lithium 4,6-Dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
Pharmaceutical impurity reference standard
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
6-chloro-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]pyridazine-3-carboxylic acid
DZLQYHBKCWHOTF-UHFFFAOYSA-N
CN1C=NC(=N1)C2=C(C(=CC=C2)NC3=CC(=NN=C3C(=O)O)Cl)OC
—